Curaleaf Holdings claims its takeover bid for Aurora Cannabis is a premium over Aurora’s current valuation. But there’s more to it than that – including cash, debt and market position. What Curaleaf’s hostile takeover bid for Aurora Cannabis is really about is a post from: MJBizDaily: Financial, Legal & CannabusinessContinue Reading

A federal ban on intoxicating hemp products expected to take effect Dec. 11 threatens to reduce retail revenue by $28.3 billion. Federal hemp rules threaten 225,000 jobs and $8.9 billion in wages is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs Read More: FederalContinue Reading

But the ruling doesn’t close out a legal challenge to marijuana rescheduling. Trump medical marijuana rescheduling order survives initial challenge is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs Read More: Trump medical marijuana rescheduling order survives initial challengeContinue Reading

In the modern day marijuana marketplace there is a dizzying array of strains to choose from, but luckily with testing methods surrounding the chemical make-up of our favorite flowers advancing just as rapidly as their development, smokers have more tools than ever before to find the strain that works bestContinue Reading

Anything over 0.4 milligrams of THC per container becomes marijuana, sellable only in licensed stores and grown in state-licensed facilities. Missouri moves intoxicating hemp into regulated market Nov. 12 is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs Read More: Missouri moves intoxicating hempContinue Reading

The national anti-marijuana group behind the push to outlaw the $1.65 billion annual Massachusetts cannabis industry is outspending the industry significantly. Campaign to criminalize Massachusetts cannabis sales heavily outspending opposition is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs Read More: Campaign to criminalizeContinue Reading

A federal appeals court has rejected a request from a drug testing industry association and a pharmaceutical company to block the Trump administration from moving forward with federal cannabis rescheduling while ongoing litigation challenging the reform is considered. “Petitioners have not satisfied the stringent requirements for a stay pending courtContinue Reading